학술논문
First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults
Document Type
Article
Author
Source
In: Vaccine . (Vaccine, 22 September 2022, 40(40):5781-5790)
Subject
Language
English
ISSN
18732518
0264410X
0264410X